Sepio Capital, LP Merrimack Pharmaceuticals Inc Transaction History

Sepio Capital, LP

$1.03 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 14, 2024	SELL	$13.06 - $15.0 $106,243 - $122,025	-8,135 Reduced 2.65%	298,545 $4.41 Million
Q3 2023 Nov 08, 2023	BUY	$11.6 - $12.52 $140,766 - $151,930	12,135 Added 4.12%	306,680 $3.78 Million
Q3 2022 Oct 28, 2022	SELL	$3.7 - $6.06 $80,541 - $131,914	-21,768 Reduced 6.88%	294,545 $1.11 Million
Q2 2022 Jul 26, 2022	BUY	$4.89 - $7.13 $96,660 - $140,938	19,767 Added 6.67%	316,313 $1.88 Million
Q1 2022 May 09, 2022	BUY	$3.75 - $6.82 $816,438 - $1.48 Million	217,717 Added 276.19%	296,546 $1.88 Million
Q3 2021 Nov 03, 2021	SELL	$4.3 - $6.39 $613,223 - $911,277	-142,610 Reduced 64.4%	78,829 $381,000
Q2 2021 Jul 26, 2021	BUY	$6.04 - $7.77 $15,293 - $19,673	2,532 Added 1.16%	221,439 $1.42 Million
Q1 2021 May 10, 2021	BUY	$6.15 - $8.7 $156,400 - $221,249	25,431 Added 13.14%	218,907 $1.38 Million
Q4 2020 Feb 10, 2021	SELL	$3.69 - $8.31 $4,830 - $10,877	-1,309 Reduced 0.67%	193,476 $1.33 Million
Q3 2020 Nov 12, 2020	SELL	$3.1 - $4.3 $48,821 - $67,720	-15,749 Reduced 7.48%	194,785 $779,000
Q2 2020 Aug 04, 2020	SELL	$2.21 - $3.88 $316,273 - $555,266	-143,110 Reduced 40.47%	210,534 $701,000
Q1 2020 Apr 29, 2020	SELL	$1.63 - $3.58 $69,340 - $152,293	-42,540 Reduced 10.74%	353,644 $760,000
Q4 2019 Feb 06, 2020	BUY	$3.15 - $4.67 $525,130 - $778,526	166,708 Added 72.65%	396,184 $1.25 Million
Q3 2019 Oct 25, 2019	BUY	$4.16 - $6.05 $954,620 - $1.39 Million	229,476 New	229,476 $1.03 Million
Q1 2019 May 14, 2019	SELL	$3.19 - $5.73 $1.31 Million - $2.36 Million	-411,676 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.95 - $4.15 $1.21 Million - $1.71 Million	411,676 New	411,676 $1.59 Million

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.